Advance Agrolife Q4 FY26 Revenue Jumps 40% to ₹125.91 Crore; PAT Up 422%
Advance Agrolife Limited reported a 40% YoY revenue increase to ₹125.91 crore in Q4 FY26, with PAT surging 422% to ₹7.46 crore. For FY26, revenue grew 28% to ₹641.75 crore and PAT by 38% to ₹35.28 crore. The company commenced production of Pretilachlor Technical and its intermediate. A new Unit-4 facility is expected by Q2 FY27.
The substantial financial growth, strategic backward integration, and expansion plans indicate a strong positive impact on the company's future performance and market position.
The company reported significant year-on-year growth in revenue, EBITDA, and PAT for Q4 FY26 and the full fiscal year FY26. The strengthening of backward integration capabilities and future expansion plans further contribute to the positive sentiment.
Advance Agrolife Limited (AAL) announced its financial results for the fourth quarter and full year ended March 31, 2026. The company reported a 40% year-on-year increase in total revenue for Q4 FY26, reaching ₹125.91 crore (1259.1 million). For the full fiscal year FY26, revenue grew by a robust 28% to ₹641.75 crore (6417.5 million) compared to FY25.
EBITDA saw a significant surge of 128% year-on-year in Q4 FY26, reaching ₹13.38 crore (133.8 million). For the full year, EBITDA increased by 34% to ₹63.69 crore (636.9 million). The EBITDA margin for Q4 FY26 stood at 10.8%, an improvement of 425 basis points year-on-year. For the full year, the EBITDA margin was 9.99%, up by 50 basis points over the previous year.
Profit After Tax (PAT) for Q4 FY26 demonstrated exceptional growth, rising by 422% to ₹7.46 crore (74.61 million). For FY26, PAT increased by 38% to ₹35.28 crore (352.84 million) compared to FY25.
During the quarter, AAL further strengthened its backward integration capabilities by commencing the production of Pretilachlor Technical and its intermediate PEDA at its manufacturing facility in Bagru, Jaipur. CARE Ratings Limited upgraded AAL's long-term bank facilities from BBB to BBB+.
Looking ahead, AAL aims to commence operations at its new Unit-4 technical manufacturing facility at Gidhani by Q2 FY27, with an estimated first-phase capital expenditure of approximately ₹25 crore (250 million). The company is also setting up a 3.75 MW solar power plant to increase renewable energy usage and reduce its carbon footprint. Additionally, AAL has entered into an MOU for land acquisition in Dahej, Gujarat, for a new technical grade pesticide manufacturing plant, proposed to be named Unit-5.
The company's strategy focuses on volume growth through capacity expansions, margin expansion via backward integration, and diversification through increased exports, aiming for exports to constitute 20% of revenue by FY29. AAL is also evolving its product mix towards specialized formulations like WDG and SC, which command higher margins.
What to do with a filing like this
Advance Agrolife Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Advance Agrolife Limited. Read the original for the full detail.